AGEN1423
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AGEN1423, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC [Phase 2]